DK1824472T3 - Anvendelse af acetyl L-carnitin til behandling af fibromyalgisyndrom - Google Patents

Anvendelse af acetyl L-carnitin til behandling af fibromyalgisyndrom

Info

Publication number
DK1824472T3
DK1824472T3 DK05807584T DK05807584T DK1824472T3 DK 1824472 T3 DK1824472 T3 DK 1824472T3 DK 05807584 T DK05807584 T DK 05807584T DK 05807584 T DK05807584 T DK 05807584T DK 1824472 T3 DK1824472 T3 DK 1824472T3
Authority
DK
Denmark
Prior art keywords
carnitine
acetyl
treatment
fibromyalgia syndrome
syndrome
Prior art date
Application number
DK05807584T
Other languages
Danish (da)
English (en)
Inventor
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1824472T3 publication Critical patent/DK1824472T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK05807584T 2004-12-13 2005-11-10 Anvendelse af acetyl L-carnitin til behandling af fibromyalgisyndrom DK1824472T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000606A ITRM20040606A1 (it) 2004-12-13 2004-12-13 Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.
PCT/EP2005/012054 WO2006063639A1 (en) 2004-12-13 2005-11-10 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome

Publications (1)

Publication Number Publication Date
DK1824472T3 true DK1824472T3 (da) 2009-03-30

Family

ID=35708966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05807584T DK1824472T3 (da) 2004-12-13 2005-11-10 Anvendelse af acetyl L-carnitin til behandling af fibromyalgisyndrom

Country Status (16)

Country Link
US (1) US8013016B2 (enExample)
EP (1) EP1824472B1 (enExample)
JP (1) JP5057990B2 (enExample)
KR (1) KR101240182B1 (enExample)
AT (1) ATE419847T1 (enExample)
CA (1) CA2585560C (enExample)
CY (1) CY1110576T1 (enExample)
DE (1) DE602005012317D1 (enExample)
DK (1) DK1824472T3 (enExample)
ES (1) ES2320788T3 (enExample)
IT (1) ITRM20040606A1 (enExample)
MX (1) MX2007006954A (enExample)
PL (1) PL1824472T3 (enExample)
PT (1) PT1824472E (enExample)
SI (1) SI1824472T1 (enExample)
WO (1) WO2006063639A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012178014A1 (en) * 2011-06-24 2012-12-27 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
ES2962933T3 (es) 2020-12-14 2024-03-21 Ims Gear Se & Co Kgaa Procedimiento para la corrección de una señal de medición dependiente del tiempo de una unidad de motor-engranaje, así como procedimiento para detectar desgaste y/o un deterioro de la misma mediante este procedimiento de corrección

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US5935949A (en) * 1998-03-20 1999-08-10 Trustees Of Dartmouth College Use of androgen therapy in fibromyalgia and chronic fatigue syndrome
US6803387B1 (en) 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
ITRM20010293A1 (it) 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
JP4584706B2 (ja) * 2002-05-03 2010-11-24 イスラエル インスティチュート フォー バイオロジカル リサーチ 中枢及び末梢神経系障害を治療するための方法及び組成物、並びにそれらに有用な新規の化合物

Also Published As

Publication number Publication date
MX2007006954A (es) 2007-08-02
JP2008534433A (ja) 2008-08-28
EP1824472A1 (en) 2007-08-29
ES2320788T3 (es) 2009-05-28
ITRM20040606A1 (it) 2005-03-13
EP1824472B1 (en) 2009-01-07
DE602005012317D1 (de) 2009-02-26
US20090076146A1 (en) 2009-03-19
PT1824472E (pt) 2009-03-31
JP5057990B2 (ja) 2012-10-24
KR101240182B1 (ko) 2013-03-07
US8013016B2 (en) 2011-09-06
SI1824472T1 (sl) 2009-04-30
WO2006063639A1 (en) 2006-06-22
PL1824472T3 (pl) 2009-05-29
ATE419847T1 (de) 2009-01-15
CA2585560C (en) 2013-01-08
CA2585560A1 (en) 2006-06-22
KR20070091317A (ko) 2007-09-10
CY1110576T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
WO2007117431A3 (en) Use of rasagiline for the treatment of restless legs syndrome
CY1107302T1 (el) Χρηση ρεσβερατρολης για την παρασκευη ενος φαρμακου που ειναι χρησιμο για τη θεραπεια λοιμωξεων απο τον ιο της γριπης
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
CY1111273T1 (el) Συνδυασμενη χρηση της l-καρνιτινης, ακετυλο l-καρνιτινης και προπιονυλο l-καρνιτινης για τη θεραπεια της ολιγοασθενοτερατοσπερμιας
CY1110576T1 (el) Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου
CY1111430T1 (el) Χρηση της αγομελατινης για τη ληψη φαρμακων που προοριζονται για τη θεραπεια του συνδρομου smith magenis
CY1111257T1 (el) Χρηση της αγομελατινης για τη ληψη φαρμακων προοριζομενων για τη θεραπεια των διπολικων διαταραχων
ITRM20020492A0 (it) Uso della propionil l-carnitina per la preparazione di un medicamentoper il trattamento del glaucoma.
CY1107037T1 (el) Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
CO5690571A2 (es) Combinacion sinergica que comprende roflumilas y (r,r)-formoterol
CY1112144T1 (el) Ενωση χρησιμη για την προληψη και θεραπεια της υπερτροφιας αριστερης κοιλιας σε ασθενεις υπο αιμοκαθαρση
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
CY1112336T1 (el) Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου)
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
SE0000332D0 (sv) New use
SI1567137T1 (sl) Uporaba resveratrola za pripravo zdravila za uporabo pri zdravljenju infekcij z virusom influence